Viewing Study NCT00479193



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00479193
Status: WITHDRAWN
Last Update Posted: 2017-09-11
First Post: 2007-05-25

Brief Title: Polymem vs BacitracinXeroform in Treating Burn Wounds
Sponsor: MetroHealth Medical Center
Organization: MetroHealth Medical Center

Study Overview

Official Title: Prospective Randomized Trial of Polymem vs BacitracinXeroform for Superficial Second Degree Burns
Status: WITHDRAWN
Status Verified Date: 2017-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients will be screened at the initial visit to the burn center If the patients are eligible according to the inclusionexclusion criteria consent for the study will be obtained One of the investigators will identify two sites that appear to be the same depth on each patient 1 site Polymen and 1 site bacitracinxeroform The depth of injury will be verified as partial thickness using laser doppler Each site will be at least 4cm x 4cm in size One site will be identified for bacitracinxeroform and one site for Polymen All burns will be initially debrided and cleaned according to burn unit protocol The dressing will then be applied All dressings will be covered with cotton gauze and ace wraps Laser Doppler will be utilized to determine burn depth at both the trial and control sites On each subsequent visit patients will rate the pain of the dressing change on a 1-10 pain intensity scale It will be noted if the wound appears infected or if antibiotics are prescribed

The study will end for each patient when the investigator determines that 95 of their burn has re-epithelized
Detailed Description: Superficial second degree burns are limited to the epidermis and superficial layer of the dermis and are expected to heal without the need of surgery if they are treated appropriately Complications such as desiccation of the wound or infection may extend the depth of the injury and result in an increase in scarring or the requirement for excision of the burn and skin grafting The MetroHealth Burn Center treats over 1500 patients a year for superficial second degree burns

Various methods are used from the conventional dressing methods using guaze to the methods that use biological materials such as skin from cadavers pigs skin and artificial synthetic materials Our present burn care involves initial superficial outpatient debridement of the burn wound and application of a dressing This dressing consists of bacitracin applied to the burn wound and xeroform covered by cotton gauze and ace-wrap The majority of our patients are unable to change this dressing by themselves and they either return to the burn center daily for wound care or we arrange for a visiting nurse

Polymem is a novel dressing which has been approved by the FDA for open wounds including burnsPolymem is a hydrophilic polyurethane membrane pad with a semi permeable polyurethane film backing The pad contains a wound cleanser F68 surfactant a moisturizer glycerin and an absorb ing agent super-absorbent polymem The F86 surfactant is involved in dissolving the superficial necrotic layer of the burn and helps clean the burn site Glycerin acts as a moisturizer and prevents the pad from sticking to the wound The absorbing agent maintains the moisture of the wound which has been shown to increase wound healing It also allows the dressing to remain on the wound for three days Kim et al conducted a study of 44 patients with second degree burns and demonstrated an increase in healing time more comfort and a decrease in dressing changes with the use of Polymem

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None